BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF
K-Number: K912284 · 1991-08-19
Advertisement
Device Summary
Frequently Asked Questions
What is the BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF?
BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF is a medical device that received FDA 510(k) clearance on 1991-08-19. The listed applicant is Douglas James Donaldson Compliance Services. The 510(k) number is K912284.
When did BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF receive FDA 510(k) clearance?
BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF received FDA 510(k) clearance on 1991-08-19, under 510(k) number K912284.
Who is the listed applicant for BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF?
The FDA 510(k) record lists Douglas James Donaldson Compliance Services as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF?
The FDA product code for BIOVISION ENDOCULAR PROBE ACCESS DELIV SYST, MODIF is GEX. This falls under the Gastroenterology category.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Douglas James Donaldson Compliance Services as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: GEX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement